Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana R Lemos

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Medical Education|October 24, 2014
The evaluation of student-centredness of teaching and learning: a new mixed-methods approachAna R Lemos, John E Sandars, Palmira Alves, et al.
International Journal of Medical Education|September 2, 2019
A structured remediation program for communication skillsPedro Morgado, Ana R Lemos, Sara Almeida, et al.
Biomolecules|March 29, 2023
Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive TumorsGabriela Silva, Ana F Rodrigues, Susana Ferreira, et al.
New Biotechnology|May 16, 2021
Development of antibodies against the notch ligand Delta-Like-1 by phage display with activity against breast cancer cellsJoana Sales-Dias, Andreia Ferreira, Márcia Lamy, et al.
Frontiers in Microbiology|May 18, 2026
Alicyclobacillin 24: a class III bacteriocin from <i>Alicyclobacillus acidoterrestris</i> targeting species associated with spoilage of acidic fruit-based productsInês Carvalho Leonardo, Ana Patrícia Quendera, Micael C Freitas, et al.
Biosensors|October 27, 2023
Extract2Chip-Bypassing Protein Purification in Drug Discovery Using Surface Plasmon ResonanceAna C F Paiva, Ana R Lemos, Philipp Busse, et al.
RSC Chemical Biology|August 30, 2021
Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitorsJoão D Seixas, Bárbara B Sousa, Marta C Marques, et al.
Cancers|August 27, 2021
Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast CancerGabriela Silva, Joana Sales-Dias, Diogo Casal, et al.
Journal of Medicinal Chemistry|June 28, 2022
Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead <b>MSC-4106</b>Timo Heinrich, Carl Peterson, Richard Schneider, et al.
Journal of Medicinal Chemistry|December 20, 2024
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686Timo Heinrich, Daniel Schwarz, Carl Petersson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Medical Education|October 24, 2014
The evaluation of student-centredness of teaching and learning: a new mixed-methods approachAna R Lemos, John E Sandars, Palmira Alves, et al.
International Journal of Medical Education|September 2, 2019
A structured remediation program for communication skillsPedro Morgado, Ana R Lemos, Sara Almeida, et al.
Biomolecules|March 29, 2023
Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive TumorsGabriela Silva, Ana F Rodrigues, Susana Ferreira, et al.
New Biotechnology|May 16, 2021
Development of antibodies against the notch ligand Delta-Like-1 by phage display with activity against breast cancer cellsJoana Sales-Dias, Andreia Ferreira, Márcia Lamy, et al.
Frontiers in Microbiology|May 18, 2026
Alicyclobacillin 24: a class III bacteriocin from <i>Alicyclobacillus acidoterrestris</i> targeting species associated with spoilage of acidic fruit-based productsInês Carvalho Leonardo, Ana Patrícia Quendera, Micael C Freitas, et al.
Biosensors|October 27, 2023
Extract2Chip-Bypassing Protein Purification in Drug Discovery Using Surface Plasmon ResonanceAna C F Paiva, Ana R Lemos, Philipp Busse, et al.
RSC Chemical Biology|August 30, 2021
Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitorsJoão D Seixas, Bárbara B Sousa, Marta C Marques, et al.
Cancers|August 27, 2021
Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast CancerGabriela Silva, Joana Sales-Dias, Diogo Casal, et al.
Journal of Medicinal Chemistry|June 28, 2022
Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead <b>MSC-4106</b>Timo Heinrich, Carl Peterson, Richard Schneider, et al.
Journal of Medicinal Chemistry|December 20, 2024
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686Timo Heinrich, Daniel Schwarz, Carl Petersson, et al.
Pageof 2